Larson SM - Search Results

1

Combined 18F-FDG and 11C-methionine PET scans in patients with newly progressive metastatic prostate cancer.

Nuñez R, Macapinlac HA, Yeung HW, Akhurst T, Cai S, Osman I, Gonen M, Riedel E, Scher HI, Larson SM. Nuñez R, et al. Among authors: larson sm. J Nucl Med. 2002 Jan;43(1):46-55. J Nucl Med. 2002. PMID: 11801702 Free article.

2

Hormone refractory prostatic cancer: the role of radiolabelled diphosphonates and growth factor inhibitors.

Scher HI, Curley T, Yeh S, Tong W, O'Moore PV, Larson S. Scher HI, et al. Adv Exp Med Biol. 1992;324:115-29. doi: 10.1007/978-1-4615-3398-6_12. Adv Exp Med Biol. 1992. PMID: 1283494 Review. No abstract available.

3

Therapeutic alternatives for hormone-refractory prostatic cancer.

Scher HI, Curley T, Yeh S, Iversen JM, O'Dell M, Larson SM. Scher HI, et al. Among authors: larson sm. Semin Urol. 1992 Feb;10(1):55-64. Semin Urol. 1992. PMID: 1373515 Review.

4

Tl-201 uptake in recurrent pigmented villonodular synovitis. Correlation with three-phase bone imaging.

Caluser C, Healey J, Macapinlac H, Kostakoglu L, Abdel-Dayem HM, Larson SM, Yeh SD. Caluser C, et al. Among authors: larson sm. Clin Nucl Med. 1992 Sep;17(9):751-3. doi: 10.1097/00003072-199209000-00020. Clin Nucl Med. 1992. PMID: 1395357 No abstract available.

5

PET scanning of iodine-124-3F9 as an approach to tumor dosimetry during treatment planning for radioimmunotherapy in a child with neuroblastoma.

Larson SM, Pentlow KS, Volkow ND, Wolf AP, Finn RD, Lambrecht RM, Graham MC, Di Resta G, Bendriem B, Daghighian F, et al. Larson SM, et al. J Nucl Med. 1992 Nov;33(11):2020-3. J Nucl Med. 1992. PMID: 1432165 Free article.

6

Radioimmunodetection in cancer identification.

Goldenberg DM, Larson SM. Goldenberg DM, et al. Among authors: larson sm. J Nucl Med. 1992 May;33(5):803-14. J Nucl Med. 1992. PMID: 1569493 Free article. Review. No abstract available.

7

In-vivo identification of tumor multidrug resistance with 3H-colchicine [corrected].

Mehta BM, Rosa E, Fissekis JD, Bading JR, Biedler JL, Larson SM. Mehta BM, et al. Among authors: larson sm. J Nucl Med. 1992 Jul;33(7):1373-7. J Nucl Med. 1992. PMID: 1613580 Free article.

8

Comparison of technetium-99m-MIBI and thallium-201-chloride uptake in primary thyroid lymphoma.

Scott AM, Kostakoglu L, O'Brien JP, Straus DJ, Abdel-Dayem HM, Larson SM. Scott AM, et al. Among authors: larson sm. J Nucl Med. 1992 Jul;33(7):1396-8. J Nucl Med. 1992. PMID: 1613584 Free article.

9

Validation of gallium-67-citrate single-photon emission computed tomography in biopsy-confirmed residual Hodgkin's disease in the mediastinum.

Kostakoglu L, Yeh SD, Portlock C, Heelan R, Yao TJ, Niedzwiecki D, Larson SM. Kostakoglu L, et al. Among authors: larson sm. J Nucl Med. 1992 Mar;33(3):345-50. J Nucl Med. 1992. PMID: 1740700 Free article.

10

Estimates of radiation absorbed dose for intraperitoneally administered iodine-131 radiolabeled B72.3 monoclonal antibody in patients with peritoneal carcinomatoses.

Larson SM, Carrasquillo JA, Colcher DC, Yokoyama K, Reynolds JC, Bacharach SA, Raubitchek A, Pace L, Finn RD, Rotman M, et al. Larson SM, et al. J Nucl Med. 1991 Sep;32(9):1661-7. J Nucl Med. 1991. PMID: 1880565 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

685 results

Search Page

Filters